Ridgetech, Inc. (RDGT) Stock Price & Analysis
Ridgetech, Inc. (RDGT) — price $1.02 (-1.40%), as of the Nov 19, 2026 trading session; market cap $3.69M.
Educational signal · not a buy or sell recommendation · How to read this
Ridgetech, Inc. · RDGT · NASDAQ
Ridgetech Inc. operates as a holding company focused on the wholesale, distribution, and retail of pharmaceutical and healthcare products. The company's operations are primarily conducted through its subsidiaries.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $1.02 | |
| Change on the day | -1.40% | |
| Market capitalisation | $3.69M | — |
| Price / earnings (trailing) | 0.00 | |
| Shares traded on the day | 4.5K |
Price & events
Other perspectives
Council score for Ridgetech (RDGT): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Ridgetech (RDGT), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Ridgetech, Inc. (RDGT) is listed on NASDAQ. It employs 64 people. In Q4 FY2026 it reported revenue of $69M and net income of -$1M. The market values it at $3.69M.
What do the latest results show for Ridgetech (RDGT)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of $69M. Against analyst estimates the company has EPS beat 0 of the last 3 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | $69M | -$1M | -$1.34 (diluted) |
| Q2 FY2026 | $63M | -$60,167 | -$231.75 (diluted) |
| Q4 FY2025 | $49M | $12M | $50850.00 (diluted) |
| Q2 FY2025 | $71M | -$2M | -$9450.00 (diluted) |
What are the financial strengths and risks for Ridgetech (RDGT)?
Short answer · as of
The distress and quality screens read Altman Z 1.23 · Piotroski F 3. Trailing ratios: ROE -3.5% · ROA -1.8% · current ratio 2.31 · earnings yield -133.0% · free-cash-flow yield -36.2%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 1.23 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-3.5%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Jul 16, 2026
- Transactions
- 9
- Identified insiders
- 2
- Purchases
- 6
- Sales
- 3
- Other transactions
- 0
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RDGT in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RDGT in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Ridgetech (RDGT)?
Ridgetech Stock: Key Questions Answered
These answers are editorial: 1 of these 8 answers is drawn from the RDGT research dossier (written May 4, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is RDGT a good stock to buy?
Stock Expert AI does not rate RDGT buy, sell or hold. Ridgetech, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the RDGT stock price today?
The last price recorded for Ridgetech, Inc. (RDGT), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Ridgetech Inc. do?
Ridgetech Inc. operates as a holding company that, through its subsidiaries, engages in the wholesale, distribution, and retail of pharmaceutical and healthcare products.
What are the key factors to evaluate for RDGT?
Evaluate RDGT on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Ridgetech Inc. operates as a holding company involved in pharmaceutical and healthcare product distribution. Not financial advice.
How frequently does RDGT data refresh on this page?
RDGT's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven RDGT's recent stock price performance?
Ridgetech, Inc. (RDGT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established distribution network in China. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RDGT overvalued or undervalued right now?
The trailing P/E of Ridgetech, Inc. (RDGT) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of RDGT?
Fractional-share availability for Ridgetech, Inc. (RDGT) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 4, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 11 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com